HK1220144A1 - -叔丁基-苄基 -氯- -氯- -乙基-苯基 -乙基 -氟- -三氟甲基-苯甲酰胺用於治療眼疾病的用途 - Google Patents
-叔丁基-苄基 -氯- -氯- -乙基-苯基 -乙基 -氟- -三氟甲基-苯甲酰胺用於治療眼疾病的用途Info
- Publication number
- HK1220144A1 HK1220144A1 HK16108350.9A HK16108350A HK1220144A1 HK 1220144 A1 HK1220144 A1 HK 1220144A1 HK 16108350 A HK16108350 A HK 16108350A HK 1220144 A1 HK1220144 A1 HK 1220144A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- chloro
- ethyl
- butylbenzyl
- benzamide
- trifluoromethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/065—Diphenyl-substituted acyclic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13187678 | 2013-10-08 | ||
PCT/EP2014/071280 WO2015052104A1 (en) | 2013-10-08 | 2014-10-06 | Use of n-(4-tert-butylbenzyl)-3-chloro-n-[2-(4-chloro-3-ethyl-phenyl)-ethyl]-2-fluoro- 5-trifluoromethyl-benzamide for the treatment of eye diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220144A1 true HK1220144A1 (zh) | 2017-04-28 |
Family
ID=49303863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108350.9A HK1220144A1 (zh) | 2013-10-08 | 2016-07-15 | -叔丁基-苄基 -氯- -氯- -乙基-苯基 -乙基 -氟- -三氟甲基-苯甲酰胺用於治療眼疾病的用途 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20170035708A1 (zh) |
EP (1) | EP3054979A1 (zh) |
JP (1) | JP2016532658A (zh) |
KR (1) | KR20160058835A (zh) |
CN (1) | CN105658239A (zh) |
BR (1) | BR112016007664A2 (zh) |
CA (1) | CA2922637A1 (zh) |
HK (1) | HK1220144A1 (zh) |
MX (1) | MX2016004410A (zh) |
RU (1) | RU2016114724A (zh) |
WO (1) | WO2015052104A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11058750B2 (en) * | 2015-12-03 | 2021-07-13 | Mor Research Applications Ltd. | Compositions and methods for treatment of ocular diseases |
JP2020537684A (ja) * | 2017-10-17 | 2020-12-24 | アペリオタス・テクノロジーズ・インコーポレイテッド | 加齢性黄斑変性症(amd)におけるスタチン療法の機能的バイオマーカー |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6218436B1 (en) * | 1993-06-28 | 2001-04-17 | The Howard Foundation | Pharmaceutically active carotenoids |
ES2299687T3 (es) * | 2002-01-30 | 2008-06-01 | Dsm Ip Assets B.V. | Luteina/zeaxantina para la proteccion contra el encandilamiento. |
US7923724B2 (en) * | 2005-01-10 | 2011-04-12 | Ovonyx, Inc. | Phase change memory that switches between crystalline phases |
US7745477B2 (en) * | 2006-02-07 | 2010-06-29 | Hoffman-La Roche Inc. | Heteroaryl and benzyl amide compounds |
JP2010509369A (ja) * | 2006-11-10 | 2010-03-25 | ジェネンテック インコーポレイテッド | 加齢黄斑変性症を処置するための方法 |
US20110313196A1 (en) * | 2010-06-18 | 2011-12-22 | Stephan Bachmann | Novel process |
US20120301439A1 (en) * | 2011-05-24 | 2012-11-29 | Washington University | Inhibition of choroidal neovascularization |
-
2014
- 2014-10-06 EP EP14786629.7A patent/EP3054979A1/en not_active Withdrawn
- 2014-10-06 CN CN201480055127.1A patent/CN105658239A/zh active Pending
- 2014-10-06 WO PCT/EP2014/071280 patent/WO2015052104A1/en active Application Filing
- 2014-10-06 CA CA2922637A patent/CA2922637A1/en not_active Abandoned
- 2014-10-06 RU RU2016114724A patent/RU2016114724A/ru not_active Application Discontinuation
- 2014-10-06 KR KR1020167009191A patent/KR20160058835A/ko not_active Application Discontinuation
- 2014-10-06 MX MX2016004410A patent/MX2016004410A/es unknown
- 2014-10-06 BR BR112016007664A patent/BR112016007664A2/pt not_active Application Discontinuation
- 2014-10-06 JP JP2016521589A patent/JP2016532658A/ja active Pending
-
2016
- 2016-04-06 US US15/091,845 patent/US20170035708A1/en not_active Abandoned
- 2016-07-15 HK HK16108350.9A patent/HK1220144A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20160058835A (ko) | 2016-05-25 |
US20170035708A1 (en) | 2017-02-09 |
MX2016004410A (es) | 2016-07-05 |
RU2016114724A (ru) | 2017-11-13 |
WO2015052104A1 (en) | 2015-04-16 |
JP2016532658A (ja) | 2016-10-20 |
EP3054979A1 (en) | 2016-08-17 |
RU2016114724A3 (zh) | 2018-07-13 |
BR112016007664A2 (pt) | 2017-08-01 |
CN105658239A (zh) | 2016-06-08 |
CA2922637A1 (en) | 2015-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL266648B (en) | A method for treating Parkinson's disease | |
IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
HK1222791A1 (zh) | 用於眼睛的光線療法的裝置 | |
HK1219943A1 (zh) | 用於治療眼科疾病和障害的取代 -苯基丙胺衍生物 | |
HUE061618T2 (hu) | Vegyület szemrendellenességek kezelésére | |
DK2919796T3 (da) | Brug af akkermansia til behandling af stofskiftesygdomme | |
EP2893903A4 (en) | IMPLANTABLE DEVICE FOR MOLDING THE CORD BEND | |
PT2959903T (pt) | Medicamento para tratar doença ocular | |
LT3210973T (lt) | Heteroarilo junginiai, skirti akių ligų gydymui | |
IL230960A0 (en) | A device for the treatment of eye disease | |
IL235874A0 (en) | Treatment of ocular inflammatory diseases by laquinimod | |
HK1221190A1 (zh) | 炎症性眼科疾病的局部治療 | |
AP2014007905A0 (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
IL230959A0 (en) | A device for the treatment of eye disease | |
HK1220144A1 (zh) | -叔丁基-苄基 -氯- -氯- -乙基-苯基 -乙基 -氟- -三氟甲基-苯甲酰胺用於治療眼疾病的用途 | |
HK1219654A1 (zh) | 用於治療眼科疾病和病症的方法 | |
HK1225971A1 (zh) | 使用拉喹莫德治療青光眼 | |
HK1223827A1 (zh) | 用於治療眼疾病的 調節劑 | |
PL3302463T3 (pl) | Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu | |
EP2979695A4 (en) | THERAPEUTIC AGENT AGAINST EYE DISEASES | |
IL241482A0 (en) | A method for treating Parkinson's disease | |
GB201306413D0 (en) | The local treatment of ophthalmic diseases | |
GB201310101D0 (en) | Treatment of freidreich's ataxia |